Moleculin Biotech (MBRX) Shares Outstanding (Entity) (2015 - 2026)
Moleculin Biotech (MBRX) recorded Shares Outstanding (Entity) of 5.68 million in Q2 2026, up 814.7% from 621,056 a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends
For FY2025, Moleculin Biotech reported Shares Outstanding (Entity) of 1.18 million, up 776.4% from FY2024.
- Annual Shares Outstanding (Entity) has increased for ten straight years, with a five-year compound annual growth rate of 107.5% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 135,156 in FY2024 (+51.7%), 89,101 in FY2023 (+16.7%), 76,345 in FY2022 (+0.2%) and 76,213 in FY2021 (+147.7%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2015.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.2% (Q4 2022) to 814.7% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - | 5.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.68 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 621,056.00 |
| Mar 31, 2025 | 373,751.00 |
| Dec 31, 2024 | 135,156.00 |
| Sep 30, 2024 | 120,076.00 |
| Jun 30, 2024 | 102,431.00 |
| Mar 31, 2024 | 92,461.00 |
| Dec 31, 2023 | 89,101.00 |
| Sep 30, 2023 | 79,498.00 |
| Jun 30, 2023 | 79,442.00 |
| Mar 31, 2023 | 78,938.00 |
| Dec 31, 2022 | 76,345.00 |
| Sep 30, 2022 | 76,345.00 |
| Jun 30, 2022 | 76,288.00 |
| Mar 31, 2022 | 76,213.00 |
| Dec 31, 2021 | 76,213.00 |
| Sep 30, 2021 | 76,209.00 |
| Jun 30, 2021 | 76,143.00 |
API Access
Moleculin Biotech Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();